FDA clearance

July 25, 2019

Triumvira Cleared to Begin Clinical Testing of TAC01-CD19 in B-cell Lymphomas

News

Triumvira Immunulogics is launching a Phase 1/2 clinical trial to test its T-cell therapy candidate, TAC01-CD19, in patients with B-cell lymphoma across the U.S. and Canada, the company announced. The ... Read more

January 12, 2018

FDA Clears Voruciclib for Phase 1 Trial as Potential Treatment for Certain B-cell Malignancies

News

The U.S. Food and Drug Administration (FDA) has cleared the way for MEI Pharma to launch a Phase 1 study of voruciclib, its oral CDK9 inhibitor, to treat people with ... Read more